The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 3 , Pages 694-702, September 2009

Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery

  • Niels Rahe-Meyer, MD, MSc, PhD

      Affiliations

    • Department of Anesthesiology, Hannover Medical School, Hannover, Germany
    • Corresponding Author InformationAddress for reprints: Niels Rahe-Meyer, MD, MSc, PhD, Hannover Medical School, Department of Anaesthesiology, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany.
  • ,
  • Cristina Solomon, MD

      Affiliations

    • Department of Anesthesiology, Hannover Medical School, Hannover, Germany
  • ,
  • Michael Winterhalter, MD

      Affiliations

    • Department of Anesthesiology, Hannover Medical School, Hannover, Germany
  • ,
  • Siegfried Piepenbrock, MD

      Affiliations

    • Department of Anesthesiology, Hannover Medical School, Hannover, Germany
  • ,
  • Kenichi Tanaka, MD, MSc, PhD

      Affiliations

    • Department of Anesthesiology, Emory University, Atlanta, Ga
  • ,
  • Axel Haverich, MD

      Affiliations

    • Department of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
  • ,
  • Maximilian Pichlmaier, MD

      Affiliations

    • Department of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany

Received 28 July 2008; received in revised form 28 October 2008; accepted 22 November 2008. published online 18 May 2009.

Objective

Thoracoabdominal aortic aneurysm operations are associated with extensive blood loss and high requirements for allogeneic blood product transfusion. We assessed the efficacy of intraoperative post–cardiopulmonary bypass administration of fibrinogen concentrate in elective thoracoabdominal aortic aneurysm surgery.

Methods

In a retrospective group (group A, n = 12) of patients undergoing elective thoracoabdominal aortic aneurysm surgery, clinically relevant diffuse bleeding after weaning from cardiopulmonary bypass was treated with allogeneic blood products (platelet concentrates, followed by fresh frozen plasma) according to a predetermined algorithm.

In a prospective group (group F, n = 6) a first therapy step with fibrinogen concentrate was added to the algorithm. The dose of fibrinogen concentrate was estimated by using thromboelastometric data (ROTEM FIBTEM). Before each step of hemostatic therapy, blood loss in the range of 60 to 250 g per 5 minutes was confirmed.

Results

In group F, administration of 7.8 ± 2.7 g of fibrinogen concentrate established hemostasis, completely avoiding intraoperative transfusion of fresh frozen plasma and platelet concentrates. Transfusion of blood products after cardiopulmonary bypass and during the 24 hours after surgical intervention was markedly lower in group F than in group A (2.5 vs 16.4 units; 4/6 patients in group F required no transfusion of blood products), as was 24-hour drainage volume (449 vs 1092 mL). Fibrinogen plasma levels, standard coagulation parameters, and hemoglobin and hematocrit values were comparable between the 2 groups on the first postoperative day.

Conclusions

FIBTEM-guided post–cardiopulmonary bypass administration of fibrinogen concentrate resulted in improved intraoperative management of coagulopathic bleeding in thoracoabdominal aortic aneurysm operations and reduced transfusion and 24-hour drainage volume.

Abbreviations and Acronyms: CPB, cardiopulmonary bypass, ECC, extracorporeal circulation, EXTEM, ROTEM test with extrinsic activation of coagulation, FFP, fresh frozen plasma, FIBTEM, ROTEM test with extrinsic activation of coagulation and platelet inhibition with cytochalasin D, ICU, intensive care unit, MCF, maximum clot firmness, PC, platelet concentrate, RBC, red blood cell, ROTEM, thromboelastometry, TAAA, thoracoabdominal aortic aneurysm, TEG, thromboelastography

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Disclosures: N.R.-M. reports lecture fees from CSL Behring, Marburg, Germany. The study was funded by CSL Behring, manufacturer of the fibrinogen concentrate described in this article.

PII: S0022-5223(09)00350-X

doi:10.1016/j.jtcvs.2008.11.065

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 3 , Pages 694-702, September 2009